|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |
Alan Bernstein, O.C., Ph.D., F.R.S.C ,
Member, Scientific Board
Executive Director
Global HIV Vaccine Enterprise
United States
Dr. Alan Bernstein is known internationally both as a researcher and as a scientific leader in the area of cancer, hematopoiesis, cardiovascular development, and functional genomics. He has published close to 200 papers. Following postdoctoral work at the Imperial Cancer Research Fund Laboratories in London, he joined the Ontario Cancer Institute and the University of Toronto in 1974. In 1985, Dr. Bernstein moved to Mount Sinai Hospital as Head of Molecular and Developmental Biology of its Samuel Lunenfeld Research Institute. He became Director in 1994, a position he held until June 2000 when he was appointed the inaugural President of the Canadian Institutes of Health Research.
Dr. Bernstein held the first Anne Tanenbaum Chair in Molecular and Developmental Biology at the Lunenfeld from 1990 to 2000. He has received numerous awards and honors for his work, including the Genetics Society of Canada Award of Excellence, the Robert L. Noble Award from the National Cancer Institute of Canada, the Royal Society of Canada's McLaughlin Medal, the 2000 Henry Friesen Award sponsored by the Canadian Society for Clinical Investigation and the Royal College of Physicians and Surgeons, and the 2001 Medal from the Australian Society for Medical Research. He is an Officer of the Order of Canada.
|
|
| |
|
|
|